FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a new compound 2-((1H-1,2,4-triazo-3-yl)thio)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-en- 1-olu of formula 1.
EFFECT: obtaining a new compound with antiparkinsonian activity, which can be used in medicine.
1 cl, 6 dwg, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
2-((1-(4R-BENZYL)-1H-1,2,3-TRIAZOL-4-YL)METHOXY)-3-METHYL-6-(PROP-1-en-2-YL)CYCLOHEX-3-en-1-ol AS ANTIPARKINSONIAN AGENT | 2023 |
|
RU2812081C1 |
3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1,2-DIOL- EPOXIDES - NEW ANTIPARKINSONIAN DRUGS AND ANTI-CONVULSANTS | 2014 |
|
RU2571299C1 |
AGENT FOR TREATMENT AND PREVENTION OF PARKINSON'S DISEASE | 2006 |
|
RU2324492C1 |
ADAMANTYL DERIVATIVES OF BENZIMIDAZOLE, HAVING ANTIPARKINSONIAN ACTIVITY | 2023 |
|
RU2820315C1 |
MEDICATION FOR TREATING PARKINSON'S DISEASE | 2009 |
|
RU2418577C1 |
INJECTABLE DOSAGE FORM FOR TREATMENT OF PARKINSON'S DISEASE, METHOD FOR PREPARING AND USING IT | 2011 |
|
RU2520758C2 |
2-METHOXY-4[(3aR,7aS)-3,3,6-TRIMETHYL-1,3,3a,4,5,7a-HEXAHYDRO-2-BENZOFURAN-1-YL]PHENOL - NOVEL AGENT FOR TREATING PARKINSON'S DISEASE | 2010 |
|
RU2436782C1 |
PEPTIDE WITH NEUROPROTECTIVE ACTIVITY ON MODEL OF MFTP-INDUCED PARKINSONISM AND A PHARMACEUTICAL COMPOSITION ON ITS BASIS | 2017 |
|
RU2662429C1 |
METHOD OF PARKINSON DISEASE TREATMENT | 1994 |
|
RU2057529C1 |
BIOLOGICALLY ACTIVE HETEROGLYCOSIDE FOR CORRECTION OF PATHOLOGICAL STATES OF CENTRAL NERVOUS SYSTEM | 2006 |
|
RU2335289C2 |
Authors
Dates
2023-05-29—Published
2022-09-12—Filed